Loading...

ADC Therapeutics SA (NYSE:ADCT)

7.89 USD +1.01 USD ( +14.68% )
Watchlist Manager
ADC Therapeutics SA
NYSE:ADCT
Watchlist

Net Margin

Net Margin measures how much net income is generated as a percentage of revenues received.

Net margin helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Current Net Margin
ADCT
-242.7%
Average Net Margin
ADCT
-1 289.6%
Industry Net Margin
Biotechnology
5.2%

Net Margin History

Statistics
Net Margin

1 Year 3 Years 5 Years
Average -1 547.5% -1 289.6% -1 289.6%
Median -1 487.8% -3 408.2% -3 408.2%
Min 0% 0% 0%
Max -242.7% -242.7% -242.7%

History Chart
Net Margin

Net Margin Across Competitors

Net Margin Comparison
ADC Therapeutics SA Competitors

Country Company Market Cap Net
Margin
CH
ADC Therapeutics SA
NYSE:ADCT
606M USD
-243%
US
Abbvie Inc
NYSE:ABBV
269B USD
22%
US
Amgen Inc
NASDAQ:AMGN
131B USD
22%
AU
CSL Ltd
ASX:CSL
128B AUD
22%
US
Gilead Sciences Inc
NASDAQ:GILD
79.2B USD
16%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
74.8B USD
31%
Country CH
Market Cap 606M USD
Net Margin
-243%
Country US
Market Cap 269B USD
Net Margin
22%
Country US
Market Cap 131B USD
Net Margin
22%
Country AU
Market Cap 128B AUD
Net Margin
22%
Country US
Market Cap 79.2B USD
Net Margin
16%
Country US
Market Cap 74.8B USD
Net Margin
31%

Profitability Report

View the profitability report to see the full profitability analysis for ADC Therapeutics SA.

See Also

Similar Stocks